Articles tagged "Kidney transplantation"

2016 American Transplant Congress
Complications of Dual Antiplatelet Therapy Among Recipients of Kidney Transplants.
F. Weng, A. Athavale, K. Hussain, K. Tibaldi, G. Rogal.
Saint Barnabas Medical Center, Livingston, NJ.
Introduction: For patients undergoing percutanous coronary intervention (PCI) with drug-eluting stents, dual antiplatelet therapy (DAPT) is often used to prevent stent thrombosis. Kidney transplantation of…
2016 American Transplant Congress
Kidney Allotransplantation Induces the Differentiation of Antigen-Experienced CD8 T Cells with Enhanced Metabolic Profiles.
G. Tilly,^1,2 M. Yap,^1,2 M. Giral,^1,2,3 S. Brouard,^1,3 C. Pecqueur,⁴ N. Degauque.^1,3
¹UMR 1064, INSERM, Nantes, France; ²Université de Nantes, Nantes, France; ³ITUN, CHU de Nantes, Nantes, France; ⁴UMR 892, INSERM, Nantes, France.
Background. Naïve and memory CD8 T cells have been shown to exhibit different metabolic profiles, especially upon antigen stimulation. However, it is unknown whether the…
2016 American Transplant Congress
Clinical Outcome of Elderly Living Kidney Donors: A Single-Center Study in Japan.
J. Hasegawa, K. Unagami, M. Okumi, K. Omoto, M. Inui, H. Ishida, K. Tanabe.
Urology, Tokyo Women's Medical University, Tokyo, Japan.
Background: Previous studies and current guidelines have suggested that elderly persons can be living kidney donors; however, reports on elderly donors >70 years old are…
2016 American Transplant Congress
Acute Rejection Profoundly Impacts Graft Survival in Young but Not in Old Kidney Transplant Recipients.
C. Denecke,^1,3 M. Biebl,^1,3 J. Fritz,² A. Brandl,^1,4 S. Weiss,^1,4 T. Dziodzio,^1,3 F. Aigner,^1,3 R. Sucher,^1,3 C. Bösmüller,¹ J. Pratschke,^1,3,4 R. Öllinger.^1,3
¹Visceral, Transplantation and Thoracic Surgery, Medical University, Innsbruck, Austria; ²Medical Statistics, Informatics and Health Economics, Medical University, Innsbruck, Austria; ³General, Visceral and Transplantation Surgery, Charité Universitätsmedizin, Campus Virchow, Berlin, Germany; ⁴General, Visceral, Vascular and Thoracic Surgery, Charite Universitätsmedizin, Campus Mitte, Berlin, Germany.
Background: The proportion of marginal grafts and elderly recipients awaiting kidney transplantation is ever increasing. The correlation of age with DGF and acute rejection determines…
2016 American Transplant Congress
Eculizumab for Chronic Antibody-Mediated Injury in Kidney Transplant Recipients: A Randomized-Controlled Trial.
S. Kulkarni,¹ N. Kirkiles-Smith,² Y. Deng,³ R. Formica,⁴ M. Gilbert,⁵ V. Broeckner,⁶ L. Bow,¹ J. Pober.²
¹Surgery, Yale University, New Haven, CT; ²Immunobiology, Yale University, New Haven, CT; ³Yale Center for Analytical Sciences, Yale School of Public Health, New Haven, CT; ⁴Medicine, Yale University, New Haven, CT; ⁵Pathology, Yale University, New Haven, CT; ⁶Histopathology, Univeristy of Cambridge, Cambridge, United Kingdom.
Purpose: We hypothesize that de novo donor specific antibody (DSA) in kidney transplant patients cause endothelial cell injury that is dependent on complement and treatment…
2016 American Transplant Congress
Impact of Allograft Dysfunction and Early Low Grade Proteinuria on Survival in Expanded Criteria Donor Kidney Transplant Recipients.
V. López, M. Cabello, P. Ruiz, C. Jironda, D. Burgos, M. González-Molina, D. Hernández.
Nephrology, Hospital Regional de Málaga, Málaga, Spain.
Introduction. Recent studies have demonstrated a relationship between low-grade proteinuria and worse graft survival, but this has not been fully studied in expanded criteria donor…
2016 American Transplant Congress
Early Posttransplant Complications Following Abo-Incompatible Kidney Transplantation.
L. Rostaing,^1,2,3 A. Allal,¹ H. Naciri Benami,¹ Z. Abdulrahman,¹ L. Esposito,¹ F. Sallusto,¹ N. Doumerc,¹ X. Game,¹ B. Debiol,¹ N. Congy,¹ N. Kamar.^1,3,4
¹Néphrologie et Transplantation d'Organes, CHU Rangueil, Toulouse, France; ²INSERM U 563, CHU Purpan, Toulouse, France; ³Faculté de Médecine de Rangueil, Université Toulouse III Paul Sabatier, Toulouse, France; ⁴INSERM U1043 CNRS UMR 5282, CHU Purpan, Toulouse, France.
Introduction: Many studies or registries particularly in Japan, but also in Western Europe, have shown that long-term results from ABO-incompatible (ABOi) living-kidney transplantation are as…
2016 American Transplant Congress
Chemoprevention of Cutaneous Squamous Cell Carcinoma in Renal Transplant Recipients: A Case-Controlled Analysis.
R. Anand, R. Hung, S. Frame, K. Bramham, M. Wain, A. Cronin.
Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom.
Organ transplant recipients are up to 200 times more likely to develop cutaneous squamous cell carcinoma (SCC) than age-matched general populations. Systemic retinoids, such as…
2016 American Transplant Congress
Transplants without Borders – A Project for In Locus Training of New Transplants Centers in Brazil.
M. Perosa,¹ J. Branez,¹ L. Mota,¹ B. Zeballos,¹ H. Noujaim,¹ L. Ianhez,¹ L. Alvim,¹ D. Machado,¹ M. Moreno,¹ T. Genzini,¹ R. Kandaswamy.²
¹Transplant Department, Bandeirantes Hospital, Sao Paulo, SP, Brazil; ²Transplant, Univ Minnesota, Minneapolis, MN.
The regional disparity in transplant activity is a huge problem in Brazil and in other countries. Brazilian transplant centers are concentrated in the coastal states,…
2016 American Transplant Congress
Advantages of Computerized Dosing Strategy in Tacrolimus Treatment of Renal Transplant Patients.
S.-Y. Kim,¹ S. Cho,¹ M.-J. Cho,¹ C. Lee,¹ A. Han,¹ C. Choi,¹ S. Ahn,¹ S.-I. Min,¹ S.-K. Min,¹ M. Park,² I. Jung,³ S. Kim,⁴ J. Ha.^1,2
¹Department of Surgery, Seoul National University Hospital, Seoul, Korea; ²Korea Organ Donation Agency, Seoul, Korea; ³Department of surgery, Seoul Metropolitan Government - Seoul National University Boramae Medical Center, Seoul, Korea; ⁴Department of Surgery, Myoungji Hospital, Goyang-si, Korea.
Purpose: Tacrolimus (Tac) is widely used in immunosuppression for kidney transplant (KT) patients. Despite this, it is still difficult for expert physicians to achieve and…